|
 |
 Search
|
CeMBR catalyzes new Alliance for Regenerative Medicine  A consortium spearheaded by Rutgers has been awarded $42.5 million over five years to create one of two academic groups that will form the Armed Forces Institute of Regenerative Medicine (AFIRM). The Rutgers-led collaboration will be headed by Professor Joachim Kohn, director of the New Jersey Center for Biomaterials and Dr. George Muschler, an orthopedic surgeon at the Cleveland Clinic – Rutgers’ principal partner in this undertaking. Learn more about AFIRM. CeMBR's Mission   Biomaterials Research CeMBR CeMBR’s mission is to support our warfighters on and off the battlefield with practical, leading edge innovations in biomaterials and tissue regeneration that are aligned with the most critical military healthcare requirements for:
combat casualty wound care
CeMBR’s research and development programs, conducted through our network of academic, industry and military project teams, span the entire innovation process from fundamental science to product scale-up and commercialization. CeMBR is a program of the New Jersey Center for Biomaterials and is supported by the Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command (TATRC, USAMRMC).tissue regeneration prosthetics and amputee care protection from chemical and biological threat agents tissue interfaces to medical devices |
||||
|
